---
title: "Bezafibrate - Hyperlipidemia"
sidebar: mydoc_sidebar
permalink: db01393-mesh-d006949-1.html
toc: false 
---


Path ID: `DB01393_MESH_D006949_1`
{% include image.html url="images/db01393-mesh-d006949-1.png" file="db01393-mesh-d006949-1.png" alt="db01393-mesh-d006949-1" %}

## Concepts

|------------|------|---------|
| Identifier | Name | Type    |
|------------|------|---------|
| <a href="https://identifiers.org/MESH:D001629">MESH:D001629 </a> | bezafibrate | Drug |
| <a href="https://identifiers.org/UniProt:P37231">UniProt:P37231 </a> | Peroxisome proliferator-activated receptor gamma | Protein |
| <a href="https://identifiers.org/UniProt:Q07869">UniProt:Q07869 </a> | Peroxisome proliferator-activated receptor alpha | Protein |
| <a href="https://identifiers.org/UniProt:Q03181">UniProt:Q03181 </a> | Peroxisome proliferator-activated receptor delta | Protein |
| <a href="https://identifiers.org/MESH:D008076">MESH:D008076 </a> | Cholesterol, HDL | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D008078">MESH:D008078 </a> | Cholesterol, LDL | ChemicalSubstance |
| <a href="https://identifiers.org/MESH:D014280">MESH:D014280 </a> | Triglycerides | ChemicalSubstance |
| <a href="https://identifiers.org/HP:0003124">HP:0003124 </a> | Hypercholesterolemia | PhenotypicFeature |
| <a href="https://identifiers.org/MESH:D006949">MESH:D006949 </a> | Hyperlipidemia | Disease |
|------------|------|---------|

## Relationships


NOTE: predicates are annotated in <a href="https://github.com/biolink/biolink-model/releases/tag/v1.3.0">Biolink Model (v1.3.0)</a>

|---------|-----------|---------|
| Subject | Predicate | Object  |
|---------|-----------|---------|
| Bezafibrate | INCREASES ACTIVITY OF | Peroxisome Proliferator-Activated Receptor Gamma |
| Bezafibrate | INCREASES ACTIVITY OF | Peroxisome Proliferator-Activated Receptor Alpha |
| Bezafibrate | INCREASES ACTIVITY OF | Peroxisome Proliferator-Activated Receptor Delta |
| Peroxisome Proliferator-Activated Receptor Gamma | DECREASES ABUNDANCE OF | Triglycerides |
| Peroxisome Proliferator-Activated Receptor Alpha | DECREASES ABUNDANCE OF | Triglycerides |
| Peroxisome Proliferator-Activated Receptor Delta | DECREASES ABUNDANCE OF | Triglycerides |
| Peroxisome Proliferator-Activated Receptor Gamma | DECREASES ABUNDANCE OF | Cholesterol, Ldl |
| Peroxisome Proliferator-Activated Receptor Alpha | DECREASES ABUNDANCE OF | Cholesterol, Ldl |
| Peroxisome Proliferator-Activated Receptor Delta | DECREASES ABUNDANCE OF | Cholesterol, Ldl |
| Peroxisome Proliferator-Activated Receptor Gamma | INCREASES ABUNDANCE OF | Cholesterol, Hdl |
| Peroxisome Proliferator-Activated Receptor Alpha | INCREASES ABUNDANCE OF | Cholesterol, Hdl |
| Peroxisome Proliferator-Activated Receptor Delta | INCREASES ABUNDANCE OF | Cholesterol, Hdl |
| Cholesterol, Ldl | POSITIVELY CORRELATED WITH | Hypercholesterolemia |
| Cholesterol, Hdl | NEGATIVELY CORRELATED WITH | Hypercholesterolemia |
| Hypercholesterolemia | POSITIVELY CORRELATED WITH | Hyperlipidemia |
| Triglycerides | POSITIVELY CORRELATED WITH | Hyperlipidemia |
|---------|-----------|---------|

Reference: 
  - [https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL264374/](https://www.ebi.ac.uk/chembl/compound_report_card/CHEMBL264374/)
  - [https://go.drugbank.com/drugs/DB01393](https://go.drugbank.com/drugs/DB01393)
  - [https://en.wikipedia.org/wiki/Bezafibrate](https://en.wikipedia.org/wiki/Bezafibrate)
  - [https://en.wikipedia.org/wiki/Lipid-lowering_agent#Established](https://en.wikipedia.org/wiki/Lipid-lowering_agent#Established)
